News of the adjustment of the list of essential medicines came out

▍Source/Cyberlan/Yaozhi.

In September of this year, the three-year basic drug catalogue adjustment may begin, and companies can seize this opportunity to increase the volume of new products.

1.

Previously, the latest news about the adjustment of essential medicines has been reported: the first draft of the adjustment of the essential medicines catalogue has been reviewed in a small range, and the adjustment of the 2021 edition of the essential medicine catalogue may be completed in September.

According to the meeting content of the previous basic medicine catalog, the basic medicine catalog management method will be adjusted accordingly after the introduction of the basic medicine catalog.

In addition, according to the spirit of the meeting, the 3-year cycle of catalogue adjustment remains unchanged, but there will be minor adjustments every year.

It is worth noting that the minutes of the discussion meeting for soliciting opinions on the national basic medicine management measures have been circulated in the industry, and the key considerations for the adjustment of basic medicines this year have emerged:

1.

2.

3.

4.

5.

For a long time, one of the advantages of national-based products is to enter the hospital.

To a certain extent, the adjustment of the basic medicine catalog will have a profound impact on the future of hospitals.

2.

On October 11, 2019, the General Office of the State Council announced the "Opinions on Further Doing a Good Job in Guaranteeing Supply and Stabilizing Prices of Drugs in Shortage" (Guobanfa [2019] No.
47).
The document clarified that it is necessary to gradually realize government-run primary medical and health institutions, In principle, the proportion of the basic medicines of the second-level public hospitals and the third-level public hospitals shall not be less than 90%, 80%, and 60%, respectively, and promote the formation of a "1+X" dominated by essential drugs at all levels of medical institutions (" 1" is the national essential drug list, "X" is non-essential drugs, determined by localities based on actual conditions) medication mode, optimize and standardize the medication structure.

In other words, basic drugs pay more attention to the basic attributes of clinically commonly used drugs, and the state encourages priority purchase and use of basic drugs.
Relevant policies stipulate that public medical institutions at all levels must be equipped with a certain amount of basic medicines before they can consider the purchase and use of other non-basic medicines.
The basic medicine is equipped according to different levels of medical institutions.
It is required that the proportion of basic medicines in primary/secondary hospitals/tertiary hospitals should not be less than 90%/80%/60%.

Previously, Cyberlan found that the top tertiary hospitals in many places in Guangdong Province had issued documents, because the proportion of the hospital’s basic medicines and the amount of money used were all up to the standard.
In order to cooperate with the policy of giving priority to the use of national basic medicines, it is recommended to clinical clinics.
The department collects the demand for replacement of national-based products; or directly implements limited use of non-based drugs in the hospital's catalogue.

Therefore, someone in the industry once told Cyberland: For agents, the greatest value of drugs is entering the hospital, and sales do not need to be innovative in nature.
As long as they enter the hospital, there will be sales; basically every hospital’s pharmacy committee It is clear that the meeting will only discuss the national-based and national-based varieties.

He said frankly: 685 national-based varieties, except for some that have no cost value, there are some varieties that can really be produced in quantity.

3.
The opportunity to increase the volume of new varieties is here

In October 2018, the National Health Commission released the 2018 edition of the National Essential Drug List, which will be implemented on November 1.
The new version of the catalog is mainly adjusted and improved on the basis of the 2012 version of the catalog.
The number of varieties has increased from 520 to 685, including 417 Western medicines and 268 proprietary Chinese medicines.

The 2018 edition of the essential medicine catalog not only increased the number (expansion of approximately 30%) and optimized the structure, but also focused on the first-line drugs that are preferred and used in clinical practice.
Incorporating a variety of innovative drugs, monoclonal antibodies, targeted anti-cancer drugs, new mechanism hypoglycemic drugs, etc.
, to expand the coverage of diseases and increase the level of drugs.

To a certain extent, the list of essential medicines is a medicine that meets basic medical and health needs, has suitable dosage forms, is reasonably priced, can guarantee supply, and is fairly available to the public.
In other words, newly added products will be more conducive to a better competitive landscape and grassroots level.
High-demand products and companies with strong sales capabilities promote the increase of such products in primary medical institutions.

In addition, according to the policy, the medicines in the medical insurance category B of the basic medicine list may also be preferentially converted to category A-entering the basic medicine list may benefit future medical insurance adjustments.

In September of this year, the three-year basic drug catalogue adjustment may begin, and companies can seize this opportunity to increase the volume of new products.